| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 17,183 | 20,548 | 32,820 | 17,992 | | Cost of Revenue | 13,654 | 13,832 | 20,961 | 12,998 | | | Gross Profit | 3,529 | 6,716 | 11,859 | 4,994 | | | Operating Expenses | | Research Development | 1,202 | 1,411 | 1,293 | 885 | | Selling General and Administrative | 6,496 | 5,567 | 6,629 | 4,827 | | Non Recurring |
-
| 264 | 140 | (1,149) | | Others | 71 | 69 | 69 | 79 | | | | Total Operating Expenses |
-
| 7,311 | 8,131 | 4,642 | | | | Operating Income or Loss | (4,240) | (595) | 3,728 | 352 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (843) | (880) | (135) | 293 | | Earnings Before Interest And Taxes | (5,083) | (1,475) | 3,593 | 645 | | Interest Expense | 205 | 221 | 458 | 232 | | Income Before Tax | (5,288) | (1,696) | 3,135 | 413 | | Income Tax Expense | (88) |
-
| (1,027) | 26 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,200) | (1,696) | 4,162 | 387 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,200) | (1,696) | 4,162 | 387 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,200) | ($1,696) | $4,162 | $387 |
|
0.04% Nasdaq 
0.0301 (2.59%) 
Income Statement
